Citius Oncology, Inc.
CTORNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $80.49M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.49$2.25
- Volume (live)
- -
- Avg. volume (3M)
- 103.19K
Citius Oncology (CTOR) Stock Price & Financial Analysis
Citius Oncology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.75 - $0.77 |
|---|---|
| 52-Week High | $2.25 |
| 52-Week Low | $0.49 |
| Open | $0.77 |
| Volume (last close) | 11.70K |
| Average Volume (3M) | 103.19K |
| Revenue (TTM) | 7.11M |
|---|---|
| Net Income (TTM) | -46.06M |
| Free Cash Flow (TTM) | -26.39M |
| EPS (TTM) | −$0.49 |
| Profit Margin | -648.32% |
| Operating Margin | -665.63% |
| Return on Equity (ROE) | -114.06% |
| Debt to Equity | 0.25 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 80.49M |
|---|---|
| Shares Outstanding | 107.89M |
| Price to Sales (P/S) | 11.33 |
| Price to Book (P/B) | 1.99 |
| EV/EBITDA | -1.80 |
| 50-Day MA | $0.87 |
|---|---|
| 200-Day MA | $0.86 |
| 1-Year Change | −56.12% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Citius Oncology at a Glance
As of the Oct 16, 2026 close, Citius Oncology (CTOR) has a market capitalization of $80.49M. The stock trades at 11.3× sales. Over the trailing twelve months it lost $46.06M on revenue of $7.11M and burned $26.39M of free cash flow.
As of its latest reported balance sheet, it holds $16.56M in cash and securities against $10.21M of debt, a net cash position of $6.35M.
Citius Oncology does not currently pay a dividend.
The share price is down 56.1% over the past year. At $0.77 (the Oct 16, 2026 close) it sits within its 52-week range of $0.49 to $2.25, below its 200-day moving average of $0.86.
Frequently Asked Questions About Citius Oncology
What is the current stock price for CTOR?
As of the Oct 16, 2026 close, CTOR stock trades at $0.77. The 52-week range is $0.49–$2.25, with a day range of $0.75–$0.77.
What is the P/E ratio for CTOR?
The P/E ratio (Price-to-Earnings) for CTOR is shown in the Key Statistics section. This valuation metric helps compare Citius Oncology, Inc. to industry peers.
Does CTOR pay dividends?
Citius Oncology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTOR?
Analyst ratings and recommendations for CTOR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CTOR?
As of the Oct 16, 2026 close, Citius Oncology's market capitalization is $82.8M, classifying it as a micro-cap company. Citius Oncology operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.